Computational study on the selective inhibition mechanism of MS402 to the first and second bromodomains of BRD4

作者: Qianqian Wang , Ying Li , Jiahui Xu , Yuwei Wang , Danfeng Shi

DOI: 10.1002/PROT.25611

关键词:

摘要: As a member of the bromodomain and extraterminal domain (BET) family, BRD4 is considered as potential target for cancer treatment. However, because highly conservation its two homologous bromodomains (BD1/BD2), selective inhibition each remains challenge. MS402 domain-selective inhibitor BRD4-BD1 over BRD4-BD2 reported recently. Understanding selectivity mechanism would be very useful further design more potent BD1-selectivity inhibitors. Molecular dynamics simulation, adaptive biasing force multiple-walker were performed to study toward here. Results demonstrate binds with lower binding free energy than BRD4-BD2. Residues Gln85, Pro86, Asn140, Ile146 are crucial MS402's selectively BRD4-BD1. needs overcome barrier dissociate from BD1 BD2 pocket. These findings will helpful rational structural modification existing inhibitors increase their BD1-selectivity.

参考文章(53)
Christophe Dhalluin, Justin E. Carlson, Lei Zeng, Cheng He, Aneel K. Aggarwal, Ming-Ming Zhou, Ming-Ming Zhou, Structure and ligand of a histone acetyltransferase bromodomain Nature. ,vol. 399, pp. 491- 496 ,(1999) , 10.1038/20974
Peng Liu, Xueguang Shao, Christophe Chipot, Wensheng Cai, The true nature of rotary movements in rotaxanes Chemical Science. ,vol. 7, pp. 457- 462 ,(2016) , 10.1039/C5SC03022F
Jian Shi, Yifan Wang, Lei Zeng, Yadi Wu, Jiong Deng, Qiang Zhang, Yiwei Lin, Junlin Li, Tiebang Kang, Min Tao, Elena Rusinova, Guangtao Zhang, Chi Wang, Haining Zhu, Jun Yao, Yi-Xin Zeng, B. Mark Evers, Ming-Ming Zhou, Binhua P. Zhou, Disrupting the Interaction of BRD4 With Diacetylated Twist Suppresses Tumorigenesis in Basal-Like Breast Cancer Cancer Cell. ,vol. 25, pp. 210- 225 ,(2014) , 10.1016/J.CCR.2014.01.028
S Mujtaba, L Zeng, M-M Zhou, Structure and acetyl-lysine recognition of the bromodomain. Oncogene. ,vol. 26, pp. 5521- 5527 ,(2007) , 10.1038/SJ.ONC.1210618
Christopher I. Bayly, Piotr Cieplak, Wendy Cornell, Peter A. Kollman, A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: the RESP model The Journal of Physical Chemistry. ,vol. 97, pp. 10269- 10280 ,(1993) , 10.1021/J100142A004
Mikolai Fajer, Robert V. Swift, J. Andrew McCammon, Using multistate free energy techniques to improve the efficiency of replica exchange accelerated molecular dynamics Journal of Computational Chemistry. ,vol. 30, pp. 1719- 1725 ,(2009) , 10.1002/JCC.21285
Thomas Fox, Peter A. Kollman, Application of the RESP Methodology in the Parametrization of Organic Solvents Journal of Physical Chemistry B. ,vol. 102, pp. 8070- 8079 ,(1998) , 10.1021/JP9717655
R. M. Rodriguez, C. Huidobro, R. G. Urdinguio, C. Mangas, B. Soldevilla, G. Domínguez, F. Bonilla, A. F. Fernandez, M. F. Fraga, Aberrant epigenetic regulation of bromodomain BRD4 in human colon cancer. Journal of Molecular Medicine. ,vol. 90, pp. 587- 595 ,(2012) , 10.1007/S00109-011-0837-0
Maria Giuseppina Baratta, Anna C. Schinzel, Yaara Zwang, Pratiti Bandopadhayay, Christian Bowman-Colin, Jennifer Kutt, Jennifer Curtis, Huiying Piao, Laura C. Wong, Andrew L. Kung, Rameen Beroukhim, James E. Bradner, Ronny Drapkin, William C. Hahn, Joyce F. Liu, David M. Livingston, An in-tumor genetic screen reveals that the BET bromodomain protein, BRD4, is a potential therapeutic target in ovarian carcinoma Proceedings of the National Academy of Sciences of the United States of America. ,vol. 112, pp. 232- 237 ,(2015) , 10.1073/PNAS.1422165112
Panagis Filippakopoulos, Stefan Knapp, Targeting bromodomains: epigenetic readers of lysine acetylation Nature Reviews Drug Discovery. ,vol. 13, pp. 337- 356 ,(2014) , 10.1038/NRD4286